XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|
Assets | ||||||||
Current assets | ||||||||
Cash, cash equivalents and short term investments | 512.34%914.3M | 512.34%914.3M | --886.8M | --831M | --801.39M | -8.48%149.31M | --149.31M | --163.14M |
-Cash and cash equivalents | 76.40%79.55M | 76.40%79.55M | --126.12M | --421.08M | --696.08M | -40.73%45.1M | --45.1M | --76.09M |
-Short-term investments | 700.99%834.75M | 700.99%834.75M | --760.68M | --409.92M | --105.31M | 19.71%104.22M | --104.22M | --87.06M |
Receivables | 365.64%38.81M | 365.64%38.81M | --25.39M | --22.23M | --16.76M | -22.26%8.34M | --8.34M | --10.72M |
-Accounts receivable | 365.64%38.81M | 365.64%38.81M | --25.39M | --22.23M | --16.76M | -22.26%8.34M | --8.34M | --10.72M |
Inventory | 79.35%43.22M | 79.35%43.22M | --24.42M | --28.57M | --29.57M | -16.55%24.1M | --24.1M | --28.87M |
Prepaid assets | ---- | ---- | ---- | ---- | --5.89M | ---- | ---- | --2.76M |
Other current assets | 309.74%16.65M | 309.74%16.65M | --8.99M | --9.45M | --835K | 698.43%4.06M | --4.06M | --509K |
Total current assets | 445.18%1.01B | 445.18%1.01B | --945.59M | --891.25M | --854.44M | -9.80%185.81M | --185.81M | --206.01M |
Non current assets | ||||||||
Net PPE | 656.60%35.65M | 656.60%35.65M | --35.14M | --21.82M | --7.58M | 33.71%4.71M | --4.71M | --3.52M |
-Gross PPE | 461.28%41.48M | 461.28%41.48M | --40M | --25.83M | --10.87M | 67.14%7.39M | --7.39M | --4.42M |
-Accumulated depreciation | -117.73%-5.83M | -117.73%-5.83M | ---4.86M | ---4.01M | ---3.29M | -198.33%-2.68M | ---2.68M | ---898K |
Other non current assets | 1.82%5.88M | 1.82%5.88M | --2.34M | --2.45M | --2.88M | 162.17%5.77M | --5.77M | --2.2M |
Total non current assets | 296.08%41.53M | 296.08%41.53M | --37.48M | --24.27M | --10.46M | 83.11%10.49M | --10.49M | --5.73M |
Total assets | 437.21%1.05B | 437.21%1.05B | --983.07M | --915.52M | --864.9M | -7.29%196.29M | --196.29M | --211.73M |
Liabilities | ||||||||
Current liabilities | ||||||||
Payables | 324.78%26.92M | 324.78%26.92M | --27.12M | --14.6M | --21.69M | -38.45%6.34M | --6.34M | --10.3M |
-accounts payable | 324.78%26.92M | 324.78%26.92M | --18.55M | --14.6M | --11.47M | -38.45%6.34M | --6.34M | --10.3M |
-Total tax payable | ---- | ---- | --8.57M | ---- | --10.22M | ---- | ---- | ---- |
Current accrued expenses | 68.05%5.42M | 68.05%5.42M | --19.42M | --26.02M | --15.51M | -82.56%3.22M | --3.22M | --18.48M |
Current debt and capital lease obligation | -40.35%1.29M | -40.35%1.29M | ---- | --2.13M | --2.33M | 35.00%2.16M | --2.16M | --1.6M |
-Current capital lease obligation | -40.35%1.29M | -40.35%1.29M | ---- | --2.13M | --2.33M | 35.00%2.16M | --2.16M | --1.6M |
Current deferred liabilities | --15M | --15M | --10M | --5M | ---- | --0 | --0 | ---- |
Other current liabilities | -0.41%8.4M | -0.41%8.4M | --8.41M | ---- | ---- | 400.83%8.44M | --8.44M | --1.69M |
Current liabilities | 146.71%86.54M | 146.71%86.54M | --88.04M | --64.07M | --45.59M | -12.50%35.08M | --35.08M | --40.09M |
Non current liabilities | ||||||||
Non current deferred liabilities | ---- | ---- | ---- | ---- | --5M | ---- | ---- | ---- |
Preferred securities outside stock equity | --0 | --0 | --0 | --0 | --0 | 0.00%255.13M | --255.13M | --255.13M |
Other non current liabilities | -16.37%3.17M | -16.37%3.17M | --1.85M | --1.3M | --1.63M | 109.69%3.79M | --3.79M | --1.81M |
Total non current liabilities | -98.78%3.17M | -98.78%3.17M | --5.41M | --6.19M | --10.53M | 0.77%258.91M | --258.91M | --256.93M |
Total liabilities | -69.49%89.71M | -69.49%89.71M | --93.45M | --70.26M | --56.12M | -1.02%293.99M | --293.99M | --297.02M |
Shareholders'equity | ||||||||
Share capital | 300.00%16K | 300.00%16K | --16K | --16K | --16K | 0.00%4K | --4K | --4K |
-common stock | 300.00%16K | 300.00%16K | --16K | --16K | --16K | 0.00%4K | --4K | --4K |
Retained earnings | -66.54%-208.8M | -66.54%-208.8M | ---233.51M | ---225.92M | ---218.37M | -26.49%-125.38M | ---125.38M | ---99.12M |
Paid-in capital | 4,179.86%1.17B | 4,179.86%1.17B | --1.12B | --1.07B | --1.03B | 95.08%27.41M | --27.41M | --14.05M |
Gains losses not affecting retained earnings | 64.48%426K | 64.48%426K | --4.43M | ---352K | ---59K | 213.10%259K | --259K | ---229K |
Total stockholders'equity | 1,087.50%964.8M | 1,087.50%964.8M | --889.61M | --845.25M | --808.78M | -14.55%-97.7M | ---97.7M | ---85.29M |
Total equity | 1,087.50%964.8M | 1,087.50%964.8M | --889.61M | --845.25M | --808.78M | -14.55%-97.7M | ---97.7M | ---85.29M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |